Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Standard precautionary principles recommend avoiding use during pregnancy absent compelling medical necessity and informed risk-benefit assessment
Targeted Fat Loss Research (Visceral, Abdominal, Subcutaneous) Not all adipose tissue behaves the same way in research settings, which is why studies on peptides for visceral fat loss are structured differently from studies examining subcutaneous or general abdominal fat
It was removed from the FDA's Category 2 restricted list on April 22, 2026, but that alone doesn't authorize compounding pharmacies to prepare it for human use
We strongly advise patients to exercise caution and consult with our experienced healthcare professionals before considering any unapproved substances or therapies
US$ 29.82
US$ 26.43
US$ 24.10
US$ 24.75
